buloxibutid — Topline data
mid-2027
ASPIRE continues as planned and remains on track to report 52-week topline results in mid-2027.Source filing
VCRE biotech catalysts & pipeline
VICORE PHARMA HOLDING AB · Data as of 2026-10-25
catalyst calendar
/
catalyst calendar
VICORE PHARMA HOLDING AB · Data as of 2026-10-25
mid-2027
ASPIRE continues as planned and remains on track to report 52-week topline results in mid-2027.Source filing